OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The protective effects of SGLT-2 inhibitors, GLP-1 receptor agonists, and RAAS blockers against renal injury in patients with type 2 diabetes
Zengguang Kuang, Ningning Hou, Chengxia Kan, et al.
International Urology and Nephrology (2022) Vol. 55, Iss. 3, pp. 617-629
Closed Access | Times Cited: 7

Showing 7 citing articles:

Slowing the Progression of Diabetic Kidney Disease
Olivia Blazek, George L. Bakris
Cells (2023) Vol. 12, Iss. 15, pp. 1975-1975
Open Access | Times Cited: 17

Comparing the effects of empagliflozin and liraglutide on lipid metabolism and intestinal microflora in diabetic mice
Qiong Yang, Ling Deng, Changmei Feng, et al.
PeerJ (2024) Vol. 12, pp. e17055-e17055
Open Access | Times Cited: 5

The Relationship between Renin–Angiotensin–Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes
Bongeka Cassandra Mkhize, Palesa Mosili, Phikelelani Sethu Ngubane, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11963-11963
Open Access | Times Cited: 7

Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets
Suye Zhong, Na Wang, Chun Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9035-9035
Open Access | Times Cited: 1

A FRMDable Future for Fibrosis?
Fiona E. Karet, Jill T. Norman
Kidney360 (2024) Vol. 5, Iss. 12, pp. 1783-1784
Open Access

GLP-1RA Combined with SGLT2 Inhibitors for the Treatment of Diabetic Kidney Disease: A Meta Analysis
莹 郭
Advances in Clinical Medicine (2023) Vol. 13, Iss. 11, pp. 18117-18130
Closed Access

Page 1

Scroll to top